Experience to rely on: the success of DR. KADE began in 1886 in a pharmacy at the Oranienplatz in Berlin. Since then we have developed from a supplier to the imperial court into an internationally active pharmaceutical manufacturer – find out more about that in our interactive history.

  • Acquisition of phytopharmaceuticals

    By acquiring six phytopharmaceuticals of Hexal, DR.KADE strengthens it’s German OTC portfolio. Included are, among others, Femikliman for the treatment of pain in the menopause and Silicur for the protection of the liver.


  • Consumer Health business of Takeda Germany

    DR. KADE acquires the Consumer Health business of Takeda Germany, including traditional and well-known brands such as Faktu, Sanostol, Riopan and Buer Lecithin, for the German market.


  • DR. KADE Avenda

    The pharmacy sales force, DR. KADE Avenda, is founded as a 100% subsidiary of DR. KADE Pharma. The sales force visits approx. 12,000 pharmacies throughout Germany. The focus of discussions is DR. KADE’s OTC product portfolio.


  • Posterisan Protect

    With Posterisan protect, DR. KADE introduces a new therapy concept in the treatment of haemorrhoidal diseases. www.posterisan.de


  • Oral Contraception

    DR. KADE enters the oral contraception market with the product Minette.
    www.schoen-sicher.de


  • Hormone Production

    At the site in Konstanz, very modern production premises for hormone production are put into operation, at which, for example, Cliovelle tablets are produced.


  • Kadefarm

    Ten years after the launch of the first products in Poland, DR. KADE founds the German-Polish joint venture Kadefarm. The new sales company is situated nearby Poznan.


  • Trancolong

    With Trancopal Dolo and Trancolong, DR. KADE launches two new innovative drugs for the treatment of back pains.


  • Non-prescription Medicine

    To expand the market position in non-prescription medicine (over-the-counter), DR. KADE begins pharmacy sales with the product ranges Posterisan and KadeFungin.


  • DR. KADE/BESINS

    The joint venture “DR. KADE/BESINS Pharma” with the Belgian company Besins Healthcare is established. Through this cooperation primarily gynaecological drugs are marketed in Germany.


  • Sales Team

    The political change in the East means further expansion for DR. KADE, which is accompanied by the set-up of a pharmaceutical sales team in the new Federal States.


  • Berlin Marienfelde

    The Berlin site is extended: in the district of Marienfelde a modern pharmaceutical site is build, in which parts of the production and quality control as well as the Marketing, Export and Medical Departments find a new home.


  • DR. KADE USA

    DR. KADE opens an office in the USA as a further international pillar.


  • Arthur Sackler

    The fourth generation of the Lutze family, Arthur Sackler, joins the management of DR. KADE.


  • OeKolp

    With Oekolp, DR. KADE introduces the first low-dose, locally administered oestrogen onto the market.


  • Konstanz

    Due to the dynamic development of business at DR. KADE as well as the uncertain political situation in Berlin, a second site is constructed in Konstanz. Parts of production and quality control, Galenic development, and sales are located here.


  • Marietta Lutze

    With Dr. Marietta Lutze the third generation takes over the management of the family company after the war. Dr. Marietta Lutze-Sackler was awarded the Federal Cross of Merit in 2007 for her work for the company and her social dedication.


  • Maruho

    The start of a business relationship with the Japanese company Maruho in Osaka revives the export business. The very successful cooperation in proctology remains to this day.


  • Posterisan

    Medical history is written with the haemorrhoid drug Posterisan. The drug, which enjoys success abroad to the current day, is based on an innovative, immunologically active bacterial culture suspension (BCS) – a milestone in development at DR. KADE.

In 1886, Dr. Franz Lutze purchased the Oranien pharmacy of the Berlin pharmacist Dr. Rudolph Kade. He retained the name of the founder – and thereby laid the cornerstone for the further history of the company. From the former pharmacy, which soon also provided drugs and bandages for the imperial yacht “Hohenzollern”, the company increasingly developed into a “pharmaceutical factory” over the following years.
In 2011 DR. KADE celebrated its 125th anniversary – and looks back to a long history: twelve and a half decades, in which the company has continually grown and helped to provide patients a better quality of life.

kadecom_historie_1886
1886 The company’s founder, Dr. Franz Lutze, purchases the “DR. KADEs Oranien” pharmacy, which was founded 26 years earlier by the pharmacist of the same name in the Kreuzberg district of Berlin. In doing so he lays the cornerstone for a successful company history.
kadecom_historie_1889
1889 The pharmacy develops into a pharmaceutical factory and one of the most important suppliers to the imperial colonial protection forces. Amongst other things the following are produced: bandaging material, medicines, first-aid kits, and surgical equipment.
kadecom_historie_1908
1908 More and more space is required for production. As a result it is relocated from the pharmacy premises and a separate factory is constructed. After World War One the pharmacy and production are separated for good.
kadecom_historie_1886
1919 The surrender of German colonies stipulated by the Treaty of Versailles causes the export business to drop severely. The son of the founder, Dr. Felix Lutze, saves the company through the turbulent postwar years.
kadecom_historie_1886
1922 Medical history is written with the hemorrhoid drug Posterisan. The drug, which enjoys success abroad to the current day, is based on an innovative, immunologically active bacterial culture suspension (BCS) – a milestone in development at DR. KADE.
kadecom_historie_1886
1923 The start of a business relationship with the Japanese company Maruho in Osaka revives the export business. The very successful cooperation in proctology remains to this day.
kadecom_historie_1886
1949 With Dr. Marietta Lutze the third generation takes over the management of the family company after the war. Dr. Marietta Lutze-Sackler was awarded the Federal Cross of Merit in 2007 for her work for the company and her social dedication.
kadecom_historie_1886
1962 Due to the dynamic development of business at DR. KADE as well as the uncertain political situation in Berlin, a second site is constructed in Konstanz. Parts of production and quality control, Galenic development, and sales are located here.
kadecom_historie_1886
1969 With Oekolp, DR. KADE introduces the first low-dose, locally administered oestrogen onto the market.
kadecom_historie_1886
1975 The fourth generation of the Lutze family, Arthur Sackler, joins the management of DR. KADE.
kadecom_historie_1886
1980 DR. KADE opens an office in the USA as a further international pillar.
kadecom_historie_1886
1982 The Berlin site is extended: in the district of Marienfelde a modern pharmaceutical site is build, in which parts of the production and quality control as well as the Marketing, Export and Medical Departments find a new home.
kadecom_historie_1886
1990 The political change in the East means further expansion for DR. KADE, which is accompanied by the set-up of a pharmaceutical sales team in the new Federal States.
kadecom_historie_1886
1992 The joint venture “DR. KADE/BESINS Pharma” with the Belgian company Besins Healthcare is established. Through this cooperation primarily gynecological drugs are marketed in Germany.
kadecom_historie_1886
2003 To expand the market position in non-prescription medicine (over-the-counter), DR. KADE begins pharmacy sales with the product ranges Posterisan and KadeFungin.
kadecom_historie_1886
2005 With Trancopal Dolo and Trancolong, DR. KADE launches two new innovative drugs for the treatment of back pains.
kadecom_historie_1886
2006 Ten years after the launch of the first products in Poland, DR. KADE founds the German-Polish joint venture Kadefarm. The new sales company is situated nearby Poznan.
kadecom_historie_1886
2009 At the site in Konstanz, very modern production premises for hormone production are put into operation, at which, for example, Cliovelle tablets are produced.
Oral Contraception
2010 DR. KADE enters the oral contraception market with the product Minette.
Posterisan Protect
2011 With Posterisan protect, DR. KADE introduces a new therapy concept in the treatment of hemorrhoidal diseases.

Facts and Figures

DR. KADE at a glance: the most important facts and figures.
DR. KADE has been developing, producing and marketing high-quality medicines since 1886 for applications in gynecology, proctology, and pain therapy.
read more

Out-Licensing

Various premium products are available for licensees or distribution partners in selected countries.
read more